| UniProt ID | MED15_HUMAN | |
|---|---|---|
| UniProt AC | Q96RN5 | |
| Protein Name | Mediator of RNA polymerase II transcription subunit 15 | |
| Gene Name | MED15 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 788 | |
| Subcellular Localization | Cytoplasm. Nucleus. | |
| Protein Description | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Required for cholesterol-dependent gene regulation. Positively regulates the Nodal signaling pathway.. | |
| Protein Sequence | MDVSGQETDWRSTAFRQKLVSQIEDAMRKAGVAHSKSSKDMESHVFLKAKTRDEYLSLVARLIIHFRDIHNKKSQASVSDPMNALQSLTGGPAAGAAGIGMPPRGPGQSLGGMGSLGAMGQPMSLSGQPPPGTSGMAPHSMAVVSTATPQTQLQLQQVALQQQQQQQQFQQQQQAALQQQQQQQQQQQFQAQQSAMQQQFQAVVQQQQQLQQQQQQQQHLIKLHHQNQQQIQQQQQQLQRIAQLQLQQQQQQQQQQQQQQQQALQAQPPIQQPPMQQPQPPPSQALPQQLQQMHHTQHHQPPPQPQQPPVAQNQPSQLPPQSQTQPLVSQAQALPGQMLYTQPPLKFVRAPMVVQQPPVQPQVQQQQTAVQTAQAAQMVAPGVQMITEALAQGGMHIRARFPPTTAVSAIPSSSIPLGRQPMAQVSQSSLPMLSSPSPGQQVQTPQSMPPPPQPSPQPGQPSSQPNSNVSSGPAPSPSSFLPSPSPQPSQSPVTARTPQNFSVPSPGPLNTPVNPSSVMSPAGSSQAEEQQYLDKLKQLSKYIEPLRRMINKIDKNEDRKKDLSKMKSLLDILTDPSKRCPLKTLQKCEIALEKLKNDMAVPTPPPPPVPPTKQQYLCQPLLDAVLANIRSPVFNHSLYRTFVPAMTAIHGPPITAPVVCTRKRRLEDDERQSIPSVLQGEVARLDPKFLVNLDPSHCSNNGTVHLICKLDDKDLPSVPPLELSVPADYPAQSPLWIDRQWQYDANPFLQSVHRCMTSRLLQLPDKHSVTALLNTWAQSVHQACLSAA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDVSGQET -------CCCCCCCC | 11.79 | - | |
| 4 | O-linked_Glycosylation | ----MDVSGQETDWR ----CCCCCCCCCHH | 30.41 | 30379171 | |
| 18 | Ubiquitination | RSTAFRQKLVSQIED HHHHHHHHHHHHHHH | 46.75 | - | |
| 21 | Phosphorylation | AFRQKLVSQIEDAMR HHHHHHHHHHHHHHH | 35.56 | 30622161 | |
| 35 | Phosphorylation | RKAGVAHSKSSKDME HHHCCCCCCCCCCHH | 25.21 | - | |
| 324 | O-linked_Glycosylation | QLPPQSQTQPLVSQA CCCCCCCCCCCHHHH | 37.08 | OGP | |
| 349 | Asymmetric dimethylarginine | QPPLKFVRAPMVVQQ CCCCCEEECCEEECC | 35.79 | - | |
| 349 | Methylation | QPPLKFVRAPMVVQQ CCCCCEEECCEEECC | 35.79 | - | |
| 405 | O-linked_Glycosylation | RARFPPTTAVSAIPS EEECCCCCCEEECCC | 30.73 | 30379171 | |
| 489 | Phosphorylation | PSPSPQPSQSPVTAR CCCCCCCCCCCCCCC | 37.73 | 26074081 | |
| 491 | Phosphorylation | PSPQPSQSPVTARTP CCCCCCCCCCCCCCC | 26.19 | 26074081 | |
| 497 | Phosphorylation | QSPVTARTPQNFSVP CCCCCCCCCCCCCCC | 27.11 | 23403867 | |
| 502 | Phosphorylation | ARTPQNFSVPSPGPL CCCCCCCCCCCCCCC | 40.44 | 28450419 | |
| 505 | Phosphorylation | PQNFSVPSPGPLNTP CCCCCCCCCCCCCCC | 40.09 | 28348404 | |
| 511 | Phosphorylation | PSPGPLNTPVNPSSV CCCCCCCCCCCHHHC | 35.98 | 28450419 | |
| 516 | Phosphorylation | LNTPVNPSSVMSPAG CCCCCCHHHCCCCCC | 30.29 | 28450419 | |
| 517 | Phosphorylation | NTPVNPSSVMSPAGS CCCCCHHHCCCCCCC | 24.09 | 28450419 | |
| 520 | Phosphorylation | VNPSSVMSPAGSSQA CCHHHCCCCCCCCHH | 14.94 | 22199227 | |
| 524 | Phosphorylation | SVMSPAGSSQAEEQQ HCCCCCCCCHHHHHH | 22.76 | 22199227 | |
| 525 | Phosphorylation | VMSPAGSSQAEEQQY CCCCCCCCHHHHHHH | 32.27 | 22199227 | |
| 532 | Phosphorylation | SQAEEQQYLDKLKQL CHHHHHHHHHHHHHH | 19.30 | 22199227 | |
| 535 | Acetylation | EEQQYLDKLKQLSKY HHHHHHHHHHHHHHH | 55.80 | 26051181 | |
| 535 | Ubiquitination | EEQQYLDKLKQLSKY HHHHHHHHHHHHHHH | 55.80 | - | |
| 542 | Phosphorylation | KLKQLSKYIEPLRRM HHHHHHHHHHHHHHH | 13.72 | 23403867 | |
| 567 | Ubiquitination | KKDLSKMKSLLDILT HHHHHHHHHHHHHHH | 41.51 | - | |
| 568 | Phosphorylation | KDLSKMKSLLDILTD HHHHHHHHHHHHHHC | 30.57 | 29083192 | |
| 574 | Phosphorylation | KSLLDILTDPSKRCP HHHHHHHHCHHHCCC | 46.31 | 29083192 | |
| 577 | Phosphorylation | LDILTDPSKRCPLKT HHHHHCHHHCCCCHH | 35.23 | 29083192 | |
| 578 | Acetylation | DILTDPSKRCPLKTL HHHHCHHHCCCCHHH | 64.51 | 26051181 | |
| 578 | Ubiquitination | DILTDPSKRCPLKTL HHHHCHHHCCCCHHH | 64.51 | 21139048 | |
| 583 | Ubiquitination | PSKRCPLKTLQKCEI HHHCCCCHHHHHHHH | 32.12 | - | |
| 583 | Acetylation | PSKRCPLKTLQKCEI HHHCCCCHHHHHHHH | 32.12 | 25953088 | |
| 584 | O-linked_Glycosylation | SKRCPLKTLQKCEIA HHCCCCHHHHHHHHH | 41.95 | 30379171 | |
| 587 | Acetylation | CPLKTLQKCEIALEK CCCHHHHHHHHHHHH | 36.63 | 26051181 | |
| 603 | Phosphorylation | KNDMAVPTPPPPPVP CCCCCCCCCCCCCCC | 41.66 | 29255136 | |
| 612 | Phosphorylation | PPPPVPPTKQQYLCQ CCCCCCCCCCHHHHH | 35.10 | 25867546 | |
| 616 | Phosphorylation | VPPTKQQYLCQPLLD CCCCCCHHHHHHHHH | 13.62 | 26074081 | |
| 631 | Phosphorylation | AVLANIRSPVFNHSL HHHHHCCCCCCCHHH | 22.94 | 22199227 | |
| 637 | Phosphorylation | RSPVFNHSLYRTFVP CCCCCCHHHHHHHHC | 28.35 | 28857561 | |
| 639 | Phosphorylation | PVFNHSLYRTFVPAM CCCCHHHHHHHHCHH | 15.60 | 24719451 | |
| 655 | Phosphorylation | AIHGPPITAPVVCTR HCCCCCCCCCEEECC | 30.59 | 24719451 | |
| 661 | Phosphorylation | ITAPVVCTRKRRLED CCCCEEECCCCCCCC | 27.84 | 24719451 | |
| 673 | Phosphorylation | LEDDERQSIPSVLQG CCCHHHCCHHHHHHH | 42.56 | 28555341 | |
| 676 | Phosphorylation | DERQSIPSVLQGEVA HHHCCHHHHHHHHHH | 33.51 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MED15_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MED15_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRI11_HUMAN | TRIM11 | physical | 16904669 | |
| MED12_HUMAN | MED12 | physical | 14657022 | |
| MED13_HUMAN | MED13 | physical | 14657022 | |
| MED1_HUMAN | MED1 | physical | 14657022 | |
| MED14_HUMAN | MED14 | physical | 14657022 | |
| MED23_HUMAN | MED23 | physical | 14657022 | |
| MED25_HUMAN | MED25 | physical | 14657022 | |
| MED16_HUMAN | MED16 | physical | 14657022 | |
| MED17_HUMAN | MED17 | physical | 14657022 | |
| MED26_HUMAN | MED26 | physical | 14657022 | |
| CDK8_HUMAN | CDK8 | physical | 14657022 | |
| MED6_HUMAN | MED6 | physical | 14657022 | |
| MED7_HUMAN | MED7 | physical | 14657022 | |
| SRBP1_HUMAN | SREBF1 | physical | 16799563 | |
| UBP2L_HUMAN | UBAP2L | physical | 22939629 | |
| SC24C_HUMAN | SEC24C | physical | 22939629 | |
| NCOA6_HUMAN | NCOA6 | physical | 22939629 | |
| MED1_HUMAN | MED1 | physical | 26344197 | |
| MED10_HUMAN | MED10 | physical | 26344197 | |
| MED11_HUMAN | MED11 | physical | 26344197 | |
| MED14_HUMAN | MED14 | physical | 26344197 | |
| MED16_HUMAN | MED16 | physical | 26344197 | |
| MED17_HUMAN | MED17 | physical | 26344197 | |
| MED24_HUMAN | MED24 | physical | 26344197 | |
| MED27_HUMAN | MED27 | physical | 26344197 | |
| MED4_HUMAN | MED4 | physical | 26344197 | |
| MED8_HUMAN | MED8 | physical | 26344197 | |
| P73_HUMAN | TP73 | physical | 25893286 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-603, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-603, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-603, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-603, AND MASSSPECTROMETRY. | |